Pharmatech Associates Adds Biotech Leader Praveen Tyle, Ph.D. to Board of Trustees
16 Jan 2024
Executive Change
HAYWARD, Calif.--(BUSINESS WIRE)--Pharmatech Associates, a subsidiary of the United States Pharmacopeia (USP), today announced it has appointed the biotech expert Dr. Praveen Tyle to its board of trustees. In nearly 40 years’ experience with small and large biotech organizations, Dr. Tyle has served as executive vice president and chief science officer at USP, and held leadership positions at Lexicon Pharmaceuticals, Osmotica Pharmaceutical, Novartis Consumer Health Group, and Bausch + Lomb.
'As we focus on providing expert consulting services to an array of biotechnology clients, Dr. Tyle\u2019s incomparable experience and valuable market insight will inform the Pharmatech Associates board'
“As we focus on providing expert consulting services to an array of biotechnology clients, Dr. Tyle’s incomparable experience and valuable market insight will inform the Pharmatech Associates board,” said Emily Kaine, Pharmatech Associates’ board chair. “Dr. Tyle’s commitment and deep understanding of USP also ensure that Pharmatech Associates’ strategic direction contributes to USP’s long term vision of advancing global access to quality medicines.”
“Pharmatech Associates’ capability building services and technical solutions for life sciences companies are a perfect complement to USP’s portfolio of standards and related programs,” said Dr. Tyle. “Backed by USP’s sustained investment and global network, Pharmatech has a promising, ambitious long-term global growth trajectory as it helps drug manufacturers meet international regulatory requirements and their own business objectives.”
About Pharmatech Associates – a USP Company
Pharmatech Associates is a global consultancy for the life science industry and advises U.S. and global drug sponsors and manufacturers that supply quality medicines in many major markets. As a wholly owned subsidiary of U.S. Pharmacopeia (USP) with domain expertise ranging from small molecule to cell and gene therapy, biologics—specifically monoclonal antibodies— and advanced manufacturing technologies, Pharmatech Associates’ services include product and process development, quality management, quality assurance, and product management. Pharmatech Associates assists clients in navigating the regulatory landscape of the FDA and international health authorities and provides guidance for U.S. market entry. Pharmatech Associates serves a range of clients from start-ups to large multi-national corporations from its headquarters in the San Francisco Bay area.
Learn more at www.pharmatechassociates.com.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
-Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.